| Literature DB >> 33244182 |
Minah Kim1,2, Wi Hoon Jung3, Geumsook Shim4, Jun Soo Kwon5,6,7.
Abstract
Whether brain network connectivity during goal-directed planning in patients with obsessive-compulsive disorder (OCD) is abnormal and restored by treatment with selective serotonin reuptake inhibitors (SSRIs) remains unknown. This study investigated whether the disrupted network connectivity during the Tower of London (ToL) planning task in medication-free OCD patients could be restored by SSRI treatment. Seventeen medication-free OCD patients and 21 matched healthy controls (HCs) underwent functional magnetic resonance imaging (fMRI) while performing the ToL task at baseline and again after 16 weeks of SSRI treatment. Internetwork connectivity was compared across the groups and treatment statuses (pretreatment versus posttreatment). At baseline, compared with the HCs, the OCD patients showed lower internetwork connectivity between the dorsal attention network and the default-mode network during the ToL planning task. After 16 weeks of SSRI treatment, the OCD patients showed improved clinical symptoms accompanied by normalized network connectivity, although their improved behavioral performance in the ToL task did not reach that of the HCs. Our findings support the conceptualization of OCD as a network disease characterized by an imbalance between brain networks during goal-directed planning and suggest that internetwork connectivity may serve as an early biomarker of the effects of SSRIs on goal-directed planning.Entities:
Mesh:
Substances:
Year: 2020 PMID: 33244182 PMCID: PMC7691328 DOI: 10.1038/s41598-020-77814-4
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Demographic and clinical characteristics of patients with obsessive–compulsive disorder (OCD) and healthy controls (HCs) at baseline and follow-up.
| OCD (N = 17) | HC (N = 21) | Statistical analysis | ||||
|---|---|---|---|---|---|---|
| χ2 or Ta | ||||||
| Sex (male/female) | 12/5 | 11/10 | 1.304 | 0.254 | ||
| Handedness (left/right) | 1/16 | 3/18 | 0.704 | 0.401 | ||
| Age (years) | 26.4 ± 6.0 | 26.0 ± 5.3 | 0.225 | 0.823 | ||
| Education years (years) | 14.3 ± 2.2 | 15.4 ± 1.7 | − 1.772 | 0.085 | ||
| IQ | 112.4 ± 9.6 | 113.5 ± 10.8 | − 0.331 | 0.742 | ||
| Age of onset (years) | 16.6 ± 6.03 | – | – | – | ||
| Duration of illness (years) | 9.9 ± 6.9 | – | – | – | ||
| – | – | – | ||||
| None | 8 (47.1) | – | – | – | ||
| Depressive disorder | 9 (52.9) | – | – | – | ||
| Bipolar disorder | – | – | – | – | ||
| Personality disorder | – | – | – | – | ||
Data are shown as the mean ± standard deviation.
SD standard deviation, IQ intelligence quotient, Y-BOCS Yale-Brown Obsessive–Compulsive Scale, HAM-D Hamilton Rating Scale for Depression, HAM-A Hamilton Rating Scale for Anxiety.
**The mean difference is significant at the 0.005 level.
aIndependent t-test or Welch's t-test if the variances were not equal; χ2 analysis or Fisher's exact test for categorical data.
bNumber (percentage) of patients who were diagnosed with each comorbid psychiatric disorder.
cPaired-samples t-test.
Behavioral performance results in the Tower of London task in patients with obsessive–compulsive disorder (OCD) and healthy controls (HCs) at baseline and follow-up.
| Time point | OCD (N = 17) | HC (N = 21) | Statistical analysisa | |||
|---|---|---|---|---|---|---|
| Difference | Z | |||||
| Baseline | 9.0 ± 2.6 | 7.5 ± 1.3 | Group | Baseline | − 1.982 | 0.048* |
| Follow-up | − 2.246 | 0.025* | ||||
| Follow-up | 8.4 ± 1.8 | 7.8 ± 1.1 | Time | OCD | − 1.633 | 0.102 |
| HC | − 1.512 | 0.131 | ||||
| Baseline | 79.3 ± 15.3 | 87.1 ± 8.2 | Group | Baseline | − 1.791 | 0.073 |
| Follow-up | − 1.794 | 0.073 | ||||
| Follow-up | 85.8 ± 8.9 | 90.2 ± 5.0 | Time | OCD | − 2.059 | 0.039* |
| HC | − 2.068 | 0.039* | ||||
| Baseline | 9.4 ± 3.3 | 12 ± 2.4 | Group | Baseline | − 2.950 | 0.003** |
| Follow-up | − 2.716 | 0.007* | ||||
| Follow-up | 10.9 ± 3.3 | 13 ± 2.1 | Time | OCD | − 2.911 | 0.004** |
| HC | − 1.999 | 0.046* | ||||
Data are shown as the mean ± standard deviation.
SD standard deviation, RT response time.
*The mean difference is significant at the 0.05 level.
**The mean difference is significant at the 0.005 level.
aMann–Whitney U test for testing the group difference; Wilcoxon signed-rank test for testing the time difference.
bAverage RT of correct responses, in second.
cPercentage (%) of correct responses.
Figure 1Group comparison of ToL planning task performance. The horizontal lines for each group indicate the means, and the vertical lines for each group indicate the standard deviations. *Indicates that the mean difference was significant at the 0.05 level.
Figure 2Results from the network analysis using statistical parametric mapping (SPM) 12 software. (a) Figures illustrating the location of nodes within each of the functional brain networks, including the dorsal attention network (DAN; red), cingulo-opercular network (CON; yellow), default-mode network (DMN; green), left frontoparietal network (LFPN; sky), and right frontoparietal network (RFPN, blue). The bottom shows activation maps of each component (i.e., functional brain networks) extracted by independent component analysis. (b) DAN–DMN and DAN–LFPC internetwork FC during performance of the ToL task. The horizontal lines for each group indicate the means, and the vertical lines for each group indicate the standard deviations. *Indicates that the mean difference is significant at the 0.05 level.
Figure 3Depiction of the task paradigm. In the planning (Tower of London) condition, participants were asked to calculate the minimum number of moves necessary to achieve the goal configuration (in the lower half of the display) by moving balls, one at a time, from the starting configuration (in the upper half). In control condition 1 (CC1), participants were asked to count all balls presented across all pictures. In control condition 2 (CC2), participants were asked to count the moved balls across all pictures. For all task conditions, participants had to press the button corresponding to the number of correct answers for each trial.